R. Medzhitov, C. Janeway, and . Jr, Decoding the Patterns of Self and Nonself by the Innate Immune System, Science, vol.296, issue.5566, pp.298-300, 2002.
DOI : 10.1126/science.1068883

O. Takeuchi and S. Akira, Pattern Recognition Receptors and Inflammation, Cell, vol.140, issue.6, pp.805-825, 2010.
DOI : 10.1016/j.cell.2010.01.022

J. Imler and J. Hoffmann, Toll receptors in innate immunity, Trends in Cell Biology, vol.11, issue.7, pp.304-315, 2001.
DOI : 10.1016/S0962-8924(01)02004-9

S. Akira, S. Uematsu, and O. Takeuchi, Pathogen Recognition and Innate Immunity, Cell, vol.124, issue.4, pp.783-801, 2006.
DOI : 10.1016/j.cell.2006.02.015

K. Takeda and S. Akira, Toll-like receptors in innate immunity, International Immunology, vol.17, issue.1, pp.1-14, 2005.
DOI : 10.1093/intimm/dxh186

B. Beutler and E. Rietschel, Timeline: Innate immune sensing and its roots: the story of endotoxin, Nature Reviews Immunology, vol.3, issue.2, pp.169-176, 2003.
DOI : 10.1038/nri1004

J. Ting, R. Lovering, E. Alnemri, J. Bertin, J. Boss et al., The NLR Gene Family: A Standard Nomenclature, Immunity, vol.28, issue.3, pp.285-292, 2008.
DOI : 10.1016/j.immuni.2008.02.005

M. Saxena and G. Yeretssian, NOD-Like Receptors: Master Regulators of Inflammation and Cancer, Frontiers in Immunology, vol.72, p.327, 2014.
DOI : 10.1158/0008-5472.CAN-11-3379

K. Schroder and J. Tschopp, The Inflammasomes, Cell, vol.140, issue.6, pp.821-853, 2010.
DOI : 10.1016/j.cell.2010.01.040

J. Magalhaes, M. Sorbara, S. Girardin, and D. Philpott, What is new with Nods?, Current Opinion in Immunology, vol.23, issue.1, pp.29-34, 2011.
DOI : 10.1016/j.coi.2010.12.003

F. Martinon, K. Burns, and J. Tschopp, The Inflammasome, Molecular Cell, vol.10, issue.2, pp.417-443, 2002.
DOI : 10.1016/S1097-2765(02)00599-3

Y. Jamilloux and T. Henry, Les inflammasomes, m??decine/sciences, vol.29, issue.11, pp.975-84, 2013.
DOI : 10.1051/medsci/20132911013

P. Menu and J. Vince, The NLRP3 inflammasome in health and disease: the good, the bad and the ugly, Clinical & Experimental Immunology, vol.75, issue.1, pp.1-15, 2011.
DOI : 10.1111/j.1365-2249.2011.04440.x

G. Guarda, M. Zenger, A. Yazdi, K. Schroder, I. Ferrero et al., Differential Expression of NLRP3 among Hematopoietic Cells, The Journal of Immunology, vol.186, issue.4, pp.2529-2563, 2011.
DOI : 10.4049/jimmunol.1002720

C. Dinarello, A Signal for the Caspase-1 Inflammasome Free of TLR, Immunity, vol.26, issue.4, pp.383-388, 2007.
DOI : 10.1016/j.immuni.2007.04.005

D. Cerretti, C. Kozlosky, B. Mosley, N. Nelson, V. Ness et al., Molecular cloning of the interleukin-1 beta converting enzyme, Science, vol.256, issue.5053, pp.97-100, 1992.
DOI : 10.1126/science.1373520

N. Thornberry, H. Bull, J. Calaycay, K. Chapman, A. Howard et al., A novel heterodimeric cysteine protease is required for interleukin-1??processing in monocytes, Nature, vol.356, issue.6372, pp.768-74, 1992.
DOI : 10.1038/356768a0

K. Schroder, R. Zhou, and J. Tschopp, The NLRP3 Inflammasome: A Sensor for Metabolic Danger?, Science, vol.327, issue.5963, pp.296-300, 2010.
DOI : 10.1126/science.1184003

A. Denes, G. Lopez-castejon, and D. Brough, Caspase-1: is IL-1 just the tip of the ICEberg?, Cell Death and Disease, vol.28, issue.7, p.338, 2012.
DOI : 10.1038/cddis.2012.86

C. Dinarello, The IL-1 family and inflammatory diseases, Clin Exp Rheumatol, vol.20, pp.1-13, 2000.

T. Eleftheriadis, G. Pissas, A. Karioti, G. Antoniadi, S. Golfinopoulos et al., Uric acid induces caspase-1 activation, IL-1? secretion and P2X7 receptor dependent proliferation in primary human lymphocytes, Hippokratia, vol.17, pp.141-146, 2013.

L. Feldmeyer, M. Keller, G. Niklaus, D. Hohl, S. Werner et al., The Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1?? by Keratinocytes, Current Biology, vol.17, issue.13, pp.1140-1145, 2007.
DOI : 10.1016/j.cub.2007.05.074

C. Garlanda, C. Dinarello, and A. Mantovani, The Interleukin-1 Family: Back to the Future, Immunity, vol.39, issue.6, pp.1003-1021, 2013.
DOI : 10.1016/j.immuni.2013.11.010

J. Sims and D. Smith, The IL-1 family: regulators of immunity, Nature Reviews Immunology, vol.9, issue.2, pp.89-102, 2010.
DOI : 10.1038/nri2691

F. Martinon, A. Mayor, and J. Tschopp, The Inflammasomes: Guardians of the Body, Annual Review of Immunology, vol.27, issue.1, pp.229-65, 2009.
DOI : 10.1146/annurev.immunol.021908.132715

F. Sutterwala, S. Haasken, and S. Cassel, Mechanism of NLRP3 inflammasome activation, Annals of the New York Academy of Sciences, vol.28, issue.1
DOI : 10.1111/nyas.12458

J. Pedra, S. Cassel, and F. Sutterwala, Sensing pathogens and danger signals by the inflammasome, Current Opinion in Immunology, vol.21, issue.1, pp.10-16, 2009.
DOI : 10.1016/j.coi.2009.01.006

C. Eder, Mechanisms of interleukin-1?? release, Immunobiology, vol.214, issue.7, pp.543-53, 2009.
DOI : 10.1016/j.imbio.2008.11.007

V. Rathinam, Z. Jiang, S. Waggoner, S. Sharma, L. Cole et al., The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses, Nature Immunology, vol.52, issue.5, pp.395-402, 2010.
DOI : 10.1084/jem.20061845

S. Mariathasan, D. Weiss, K. Newton, J. Mcbride, O. Rourke et al., Cryopyrin activates the inflammasome in response to toxins and ATP, Nature, vol.46, issue.7081, pp.228-260, 2006.
DOI : 10.1038/nature04515

T. Gicquel, T. Victoni, A. Fautrel, S. Robert, F. Gleonnec et al., Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages, Clinical and Experimental Pharmacology and Physiology, vol.15, issue.4, pp.279-86, 2014.
DOI : 10.1111/1440-1681.12214
URL : https://hal.archives-ouvertes.fr/hal-01134782

F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, vol.20, issue.7081, pp.237-278, 2006.
DOI : 10.1038/nature04516

T. Gicquel, S. Robert, P. Loyer, T. Victoni, A. Bodin et al., IL-1? production is dependent of the activation of purinergic receptors and NLRP3 pathway in human macrophages, FASEB J, vol.pii, pp.14-267393, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01169797

F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Núñez et al., Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome, The Journal of Immunology, vol.187, issue.2, pp.613-620, 2011.
DOI : 10.4049/jimmunol.1100613

O. Gross, A. Yazdi, C. Thomas, M. Masin, L. Heinz et al., Inflammasome Activators Induce Interleukin-1?? Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1, Immunity, vol.36, issue.3, pp.388-400, 2012.
DOI : 10.1016/j.immuni.2012.01.018

A. Halle, V. Hornung, G. Petzold, C. Stewart, B. Monks et al., The NALP3 inflammasome is involved in the innate immune response to amyloid-??, Nature Immunology, vol.17, issue.8, pp.857-65, 2008.
DOI : 10.1126/science.1067081

C. Dostert, V. Pétrilli, R. Van-bruggen, C. Steele, B. Mossman et al., Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica, Science, vol.320, issue.5876, pp.674-77, 2008.
DOI : 10.1126/science.1156995

V. Hornung, F. Bauernfeind, A. Halle, E. Samstad, H. Kono et al., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization, Nature Immunology, vol.109, issue.8, pp.847-856, 2008.
DOI : 10.1016/0008-8749(88)90236-5

S. Cassel, S. Eisenbarth, S. Iyer, J. Sadler, O. Colegio et al., The Nalp3 inflammasome is essential for the development of silicosis, Proceedings of the National Academy of Sciences, vol.105, issue.26, pp.9035-9040, 2008.
DOI : 10.1073/pnas.0803933105

A. Yazdi, G. Guarda, N. Riteau, S. Drexler, A. Tardivel et al., Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1?? and IL-1??, Proceedings of the National Academy of Sciences, vol.107, issue.45, pp.19449-54, 2010.
DOI : 10.1073/pnas.1008155107

F. Martinon, Signaling by ROS drives inflammasome activation, European Journal of Immunology, vol.454, issue.3, pp.616-625, 2010.
DOI : 10.1038/ni.1831

V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon et al., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration, Cell Death and Differentiation, vol.282, issue.9, pp.1583-1592, 2007.
DOI : 10.1128/MCB.26.3.735-742.2006

H. Ea, Physiopathologie de l???inflammation goutteuse, La Presse M??dicale, vol.40, issue.9, pp.836-879, 2011.
DOI : 10.1016/j.lpm.2011.03.016

F. Martinon, Mechanisms of uric acid crystal-mediated autoinflammation, Immunological Reviews, vol.172, issue.Suppl 1, pp.218-250, 2010.
DOI : 10.1111/j.0105-2896.2009.00860.x

Y. Shi, J. Evans, and K. Rock, Molecular identification of a danger signal that alerts the immune system to dying cells, Nature, vol.425, issue.6957, pp.516-537, 2003.
DOI : 10.1038/nature01991

P. Gasse, N. Riteau, S. Charron, S. Girre, L. Fick et al., Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.10, pp.903-916, 2009.
DOI : 10.1164/rccm.200808-1274OC
URL : https://hal.archives-ouvertes.fr/hal-00404885

R. Liu-bryan, P. Scott, A. Sydlaske, D. Rose, and R. Terkeltaub, Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation, Arthritis & Rheumatism, vol.82, issue.9, pp.2936-2982, 2005.
DOI : 10.1002/art.21238

P. Scott, H. Ma, S. Viriyakosol, R. Terkeltaub, and R. Liu-bryan, Engagement of CD14 Mediates the Inflammatory Potential of Monosodium Urate Crystals, The Journal of Immunology, vol.177, issue.9, pp.6370-6378, 2006.
DOI : 10.4049/jimmunol.177.9.6370

C. Chen, Y. Shi, A. Hearn, K. Fitzgerald, D. Golenbock et al., MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals, Journal of Clinical Investigation, vol.116, issue.8, pp.2262-2271, 2006.
DOI : 10.1172/JCI28075

G. Ng, K. Sharma, S. Ward, M. Desrosiers, L. Stephens et al., Receptor-Independent, Direct Membrane Binding Leads to Cell-Surface Lipid Sorting and Syk Kinase Activation in Dendritic Cells, Immunity, vol.29, issue.5, pp.807-825, 2008.
DOI : 10.1016/j.immuni.2008.09.013

A. Gombault, L. Baron, and I. Couillin, ATP release and purinergic signaling in NLRP3 inflammasome activation, Frontiers in Immunology, vol.3, p.414, 2013.
DOI : 10.3389/fimmu.2012.00414

G. Lee, N. Subramanian, A. Kim, I. Aksentijevich, R. Goldbach-mansky et al., The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP, Nature, vol.9, issue.7427, pp.123-130, 2012.
DOI : 10.1038/nature11588

A. Villani, M. Lemire, G. Fortin, E. Louis, M. Silverberg et al., Common variants in the NLRP3 region contribute to Crohn's disease susceptibility, Nature Genetics, vol.52, issue.1, pp.71-77, 2009.
DOI : 10.1073/pnas.88.16.7276

Y. Jamilloux, P. Sève, and T. Henry, Les inflammasomes et les maladies humaines, La Revue de M??decine Interne, vol.35, issue.11, pp.730-771, 2014.
DOI : 10.1016/j.revmed.2014.04.017

S. Rosengren, H. Hoffman, W. Bugbee, and D. Boyle, Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium, Annals of the Rheumatic Diseases, vol.64, issue.5, pp.708-722, 2005.
DOI : 10.1136/ard.2004.025577

S. Masters, A. Simon, I. Aksentijevich, and D. Kastner, : The Molecular Pathophysiology of Autoinflammatory Disease, Annual Review of Immunology, vol.27, issue.1, pp.621-68, 2009.
DOI : 10.1146/annurev.immunol.25.022106.141627

C. Boschan, O. Witt, P. Lohse, I. Foeldvari, H. Zappel et al., Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment, Am J Med Genet A, vol.140, pp.883-889, 2006.

L. Agostini, F. Martinon, K. Burns, M. Mcdermott, P. Hawkins et al., NALP3 Forms an IL-1??-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder, Immunity, vol.20, issue.3, pp.319-344, 2004.
DOI : 10.1016/S1074-7613(04)00046-9

H. De-koning, J. Schalkwijk, M. Stoffels, J. Jongekrijg, J. Jacobs et al., The role of interleukin-1 beta in the pathophysiology of Schnitzler???s syndrome, Arthritis Research & Therapy, vol.84, issue.2, p.187, 2015.
DOI : 10.1186/s13075-015-0696-0

S. Stojanovic, K. Georgin-lavialle, S. Grateau, and G. , Fi??vres r??currentes h??r??ditaires, Annales de Dermatologie et de V??n??r??ologie, vol.141, issue.8-9, pp.538-583, 2014.
DOI : 10.1016/j.annder.2014.06.005

I. Aksentijevich, C. Putnam, E. Remmers, J. Mueller, J. Le et al., The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin model, Arthritis & Rheumatism, vol.366, issue.4, pp.1273-1285, 2007.
DOI : 10.1002/art.22491

A. Omenetti, S. Carta, L. Delfino, A. Martini, M. Gattorno et al., genotype, Annals of the Rheumatic Diseases, vol.6, issue.2, pp.462-471, 2014.
DOI : 10.1136/annrheumdis-2012-202774

A. De-jesus, S. Canna, Y. Liu, and R. Goldbach-mansky, Molecular Mechanisms in Genetically Defined Autoinflammatory Diseases: Disorders of Amplified Danger Signaling, Annual Review of Immunology, vol.33, issue.1, pp.823-74, 2015.
DOI : 10.1146/annurev-immunol-032414-112227

I. Jéru, P. Duquesnoy, T. Fernandes-alnemri, E. Cochet, J. Yu et al., Mutations in NALP12 cause hereditary periodic fever syndromes, Proceedings of the National Academy of Sciences, vol.105, issue.5, pp.1614-1623, 2008.
DOI : 10.1073/pnas.0708616105

R. Vance, The NAIP/NLRC4 inflammasomes, Current Opinion in Immunology, vol.32, pp.84-93, 2015.
DOI : 10.1016/j.coi.2015.01.010

A. Kitamura, Y. Sasaki, T. Abe, H. Kano, and K. Yasutomo, causes autoinflammation in human and mice, The Journal of Experimental Medicine, vol.211, issue.12, pp.2385-96, 2014.
DOI : 10.1038/nature10510

L. Church and M. Mcdermott, Canakinumab: a human anti-IL-1?? monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes, Expert Review of Clinical Immunology, vol.6, issue.6, pp.831-872, 2010.
DOI : 10.1586/eci.10.66

E. Dubois, R. Rissmann, and A. Cohen, Rilonacept and canakinumab, British Journal of Clinical Pharmacology, vol.22, issue.5, pp.639-680, 2011.
DOI : 10.1111/j.1365-2125.2011.03958.x

S. Hoy, Canakinumab: A Review of Its Use in the Management of Systemic Juvenile Idiopathic Arthritis, BioDrugs, vol.66, issue.9, pp.133-175, 2015.
DOI : 10.1007/s40259-015-0123-8

N. Wulffraat and P. Woo, Canakinumab in pediatric rheumatic diseases, Expert Opinion on Biological Therapy, vol.64, issue.7, pp.615-637, 2013.
DOI : 10.1002/art.34348

W. Martin, M. Walton, and J. Harper, Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout, Arthritis & Rheumatism, vol.38, issue.1, pp.281-290, 2009.
DOI : 10.1002/art.24185

J. Hirsch, A. Gnanasakthy, R. Lale, K. Choi, and A. Sarkin, Efficacy of Canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures, International Journal of Clinical Practice, vol.12, issue.12, pp.1503-1510, 2014.
DOI : 10.1111/ijcp.12521

W. Arend and C. Gabay, Physiologic role of interleukin-1 receptor antagonist, Arthritis Research, vol.2, issue.4, pp.245-253, 2000.
DOI : 10.1186/ar94

C. Dinarello, The Role of the Interleukin-1???Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1, New England Journal of Medicine, vol.343, issue.10, pp.732-736, 2000.
DOI : 10.1056/NEJM200009073431011

K. Chauffier, J. London, C. Beaudouin, and B. Fautrel, Indications de l???anakinra, La Presse M??dicale, vol.38, issue.5, pp.799-807, 2009.
DOI : 10.1016/j.lpm.2009.01.012

P. Hawkins, H. Lachmann, E. Aganna, and M. Mcdermott, Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra, Arthritis & Rheumatism, vol.358, issue.2, pp.607-619, 2004.
DOI : 10.1002/art.20033

X. Li, C. Zhang, W. Chen, B. Pan, F. Kong et al., Protective effect of neutralizing anti-IL-18?? monoclonal antibody on a mouse model of acute graft-versus-host disease, Oncology Reports, vol.34, pp.2031-2040, 2015.
DOI : 10.3892/or.2015.4176

N. Nishina, Y. Kaneko, H. Kameda, and T. Takeuchi, The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study, Modern Rheumatology, vol.7, issue.4, pp.401-405, 2015.
DOI : 10.3109/s10165-011-0569-6

K. Krause, E. Feist, M. Fiene, T. Kallinich, and M. Maurer, Complete remission in 3 of 3 anti-IL-6???treated patients with Schnitzler syndrome, Journal of Allergy and Clinical Immunology, vol.129, issue.3, pp.848-50, 2012.
DOI : 10.1016/j.jaci.2011.10.031

R. Coll, A. Robertson, J. Chae, S. Higgins, R. Muñoz-planillo et al., A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases, Nature Medicine, vol.1040, pp.248-55, 2015.
DOI : 10.1038/nm.3806

Y. Youm, K. Nguyen, R. Grant, E. Goldberg, M. Bodogai et al., The ketone metabolite ??-hydroxybutyrate blocks NLRP3 inflammasome???mediated inflammatory disease, Nature Medicine, vol.488, pp.263-272, 2015.
DOI : 10.1038/nm.3804